Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
PUT
Fortune Brands Innovations
FBIN
$4.7B
| $807K | ﹤0.01% |
+14,700
| New | +$589K |
|
|
KZIA
2902
Kazia Therapeutics
KZIA
$149M
| $803K | ﹤0.01% |
56,999
+33,000
| +138% | +$402K |
|
2903
CALL
Centene
CNC
$30.5B
| $802K | ﹤0.01% |
+12,500
| New | +$668K |
|
2904
CALL
Argan
AGX
$5.11B
| $799K | ﹤0.01% |
+1,000
| New | +$665K |
|
|
2905
PUT
Argan
AGX
$5.11B
| $799K | ﹤0.01% |
+1,000
| New | +$665K |
|
2906
CALL
Meritage Homes
MTH
$4.24B
| $797K | ﹤0.01% |
9,500
-3,000
| -24% | -$205K |
|
|
MCHB
2907
Mechanics Bancorp
MCHB
$3.36B
| $794K | ﹤0.01% |
49,965
-2,436
| -5% | -$36.5K |
|
2908
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.1B
| $794K | ﹤0.01% |
+14,132
| New | +$765K |
|
2909
Backblaze
BLZE
$816M
| $793K | ﹤0.01% |
50,004
-48,376
| -49% | -$335K |
|
2910
Gorman-Rupp
GRC
$1.96B
| $792K | ﹤0.01% |
8,632
+4,006
| +87% | +$304K |
|
2911
Mirion Technologies
MIR
$3.79B
| $791K | ﹤0.01% |
44,128
+338
| +0.8% | +$6.27K |
|
2912
Absci
ABSI
$1.67B
| $789K | ﹤0.01% |
68,058
-14,465
| -18% | -$81.5K |
|
2913
Oil-Dri
ODC
$1.28B
| $788K | ﹤0.01% |
7,708
-1,179
| -13% | -$94.3K |
|
|
SHOE
2914
Shoe Station Group
SHOE
$353M
| $783K | ﹤0.01% |
52,816
-1,359
| -3% | -$23.2K |
|
2915
BioLife Solutions
BLFS
$1.88B
| $783K | ﹤0.01% |
27,717
-2,348
| -8% | -$54.9K |
|
2916
The RMR Group
RMR
$316M
| $781K | ﹤0.01% |
38,050
-1,093
| -3% | -$20.7K |
|
2917
CALL
HCA Healthcare
HCA
$94.3B
| $780K | ﹤0.01% |
2,000
-36,000
| -95% | -$15.2M |
|
|
BOW
2918
Bowhead Specialty Holdings
BOW
$1.11B
| $778K | ﹤0.01% |
25,981
-1,802
| -6% | -$46.9K |
|
2919
Usana Health Sciences
USNA
$268M
| $777K | ﹤0.01% |
36,400
+1,159
| +3% | +$21.8K |
|
2920
PubMatic
PUBM
$847M
| $774K | ﹤0.01% |
59,016
-17,890
| -23% | -$186K |
|
2921
AtriCure
ATRC
$2.97B
| $772K | ﹤0.01% |
27,582
+9,447
| +52% | +$266K |
|
2922
RXO
RXO
$3.26B
| $771K | ﹤0.01% |
27,954
-2,227
| -7% | -$49.2K |
|
2923
Zentalis Pharmaceuticals
ZNTL
$256M
| $770K | ﹤0.01% |
158,856
-432,361
| -73% | -$1.73M |
|
|
WAY
2924
Waystar Holding Corp
WAY
$4.74B
| $768K | ﹤0.01% |
37,396
-11,231
| -23% | -$236K |
|
2925
USCB Financial Holdings
USCB
$418M
| $766K | ﹤0.01% |
37,419
-3,885
| -9% | -$73.9K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.